As of 2026-04-12, the Relative Valuation of Fortress Biotech Inc (FBIO) is 2.99 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.35 USD, the upside of Fortress Biotech Inc based on Relative Valuation is 27.1%.
The range of the Relative Valuation is 2.73 - 3.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 26.6x | 24.5x |
| Forward P/E multiples | 21.2x - 25.1x | 22.0x |
| Fair Price | 2.73 - 3.42 | 2.99 |
| Upside | 16.0% - 45.4% | 27.1% |
| Date | P/E |
| 2026-04-10 | 18.30 |
| 2026-04-09 | 18.68 |
| 2026-04-08 | 17.98 |
| 2026-04-07 | 18.30 |
| 2026-04-06 | 19.54 |
| 2026-04-02 | 20.24 |
| 2026-04-01 | 19.23 |
| 2026-03-31 | 21.72 |
| 2026-03-30 | 21.02 |
| 2026-03-27 | 21.49 |
| 2026-03-26 | 22.42 |
| 2026-03-25 | 23.28 |
| 2026-03-24 | 22.73 |
| 2026-03-23 | 23.20 |
| 2026-03-20 | 23.28 |
| 2026-03-19 | 24.45 |
| 2026-03-18 | 24.60 |
| 2026-03-17 | 24.29 |
| 2026-03-16 | 24.06 |
| 2026-03-13 | 24.13 |
| 2026-03-12 | 25.54 |
| 2026-03-11 | 25.07 |
| 2026-03-10 | 26.16 |
| 2026-03-09 | 26.24 |
| 2026-03-06 | 26.00 |
| 2026-03-05 | 24.37 |
| 2026-03-04 | 24.13 |
| 2026-03-03 | 23.82 |
| 2026-03-02 | 25.69 |
| 2026-02-27 | 26.63 |
| 2026-02-26 | 27.40 |
| 2026-02-25 | 27.64 |
| 2026-02-24 | 27.56 |
| 2026-02-23 | 26.86 |
| 2026-02-20 | 26.16 |
| 2026-02-19 | 27.09 |
| 2026-02-18 | 26.86 |
| 2026-02-17 | 27.25 |
| 2026-02-13 | 28.10 |
| 2026-02-12 | 27.17 |
| 2026-02-11 | 28.57 |
| 2026-02-10 | 29.19 |
| 2026-02-09 | 28.49 |
| 2026-02-06 | 25.46 |
| 2026-02-05 | 22.81 |
| 2026-02-04 | 23.98 |
| 2026-02-03 | 24.06 |
| 2026-02-02 | 24.52 |
| 2026-01-30 | 24.13 |
| 2026-01-29 | 26.16 |